Skip to content

The effect of Vitamin D3 supplementation on blood pressure, bone parameters, lipid profile, liver enzymes, glycemic and hematopoietic indices in pregnant women with Vitamin D deficiency

The effect of Vitamin D supplementation on blood pressure, bone parameters, lipid profile, liver enzymes, glycemic and hematopoietic indices in pregnant women with vitamin D deficiency

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014091619162N5
Enrollment
30
Registered
2015-03-26
Start date
2014-12-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitamin D Deficiency. Vitamin D Deficiency, unspecified

Interventions

In the first stage of Intervention: to give a 50000 Units of Vitamin D weekly for 12 weeks. In the second stage of intervention:to give a 50000 Units of Vitamin D monthly for 3 months..
Treatment - Drugs
In the first stage of Intervention: to give a 50000 Units of Vitamin D weekly for 12 weeks. In the second stage of intervention:to give a 50000 Units of Vitamin D monthly for 3 months.

Sponsors

Baqiyatallah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: women between 14-12 weeks of pregnancy; the level of serum 25OHD<20ng /ml; with a body mass index less than 30 Kg/m2; age less than 35 years; normal blood pressure; not having any systemic disease such as Cardiovascular disease; renal disease, diabetes, heart disease, liver disease; In the past 6 months did not receive vitamin D supplements; not to have calcium deficiency; not smoking; and alcohol consumption; Not taking anticonvulsant drugs or any other drugs; singleton pregnancy; first pregnancy or 3 years spacing between two pregnancy. Exclusion criteria: presence of any systemic disease.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Magnesium. Timepoint: Three times: 1) before supplementation 2)After weekly supplementation for 12 weeks 3) Delivery time. Method of measurement: In milligrams per deciliter and by autoanalyzer.;Phosphor. Timepoint: Three times: 1) before supplementation 2)After weekly supplementation for 12 weeks 3) Delivery time. Method of measurement: In milligrams per deciliter and by autoanalyzer.;Calcium. Timepoint: Three times: 1) before supplementation 2)After weekly supplementation for 12 weeks 3) Delivery time. Method of measurement: In milligrams per deciliter and by autoanalyzer.;PTH. Timepoint: Three times: 1) before supplementation 2)After weekly supplementation for 12 weeks 3) Delivery time. Method of measurement: In milligrams per deciliter and by autoanalyzer.;Alkaline Phosphatase. Timepoint: Three times: 1) before supplementation 2)After weekly supplementation for 12 weeks 3) Delivery time. Method of measurement: In milligrams per deciliter and by autoanalyzer.;25OHD Serum. Timepoint: Three times: 1) before supplementation 2)After weekly supplementation for 12 weeks 3) Delivery time. Method of measurement: Units are ng / ml using 25OHD ALIZA.;Diastolic Blood Pressure. Timepoint: Three times: 1) before supplementation 2)After weekly supplementation for 12 weeks 3) Delivery time. Method of measurement: In millimeters of mercury sphygmomanometer.;Systole Blood Pressure. Timepoint: Three times: 1) before supplementation 2)After weekly supplementation for 12 weeks 3) Delivery time. Method of measurement: In millimeters of mercury sphygmomanometer.;FBS. Timepoint: Three times: 1) before supplementation 2)After weekly supplementation for 12 weeks 3) Delivery time. Method of measurement: Units are mg / dl using autoanalyzer.;Insulin. Timepoint: Three times: 1) before supplementation 2)After weekly supplementation for 12 weeks 3) Delivery time. Method of measurement: Units are µIU / ml using insulin kits.;Insulin Resistance. Timepoint: Three times: 1) before supplementation

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTahereh Babashamsi, Saeideh Nahani, Simindokht Esmaeilzadeh

Baqiyatallah University of Medical Sciences

babashamsi@gmail.com ssaeideh1@yahoo.com simin747@gmail.com00982144704033 00982166686697 00982177872648

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026